Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

China flag China · Delayed Price · Currency is CNY
15.01
+0.17 (1.15%)
At close: Jan 23, 2026
-3.16%
Market Cap8.58B
Revenue (ttm)1.90B
Net Income (ttm)143.32M
Shares Out571.39M
EPS (ttm)0.26
PE Ratio57.56
Forward PE27.59
Dividend0.21 (1.40%)
Ex-Dividend DateJun 27, 2025
Volume6,080,501
Average Volume9,099,547
Open14.92
Previous Close14.84
Day's Range14.86 - 15.05
52-Week Range13.80 - 18.10
Beta0.58
RSI51.18
Earnings DateApr 29, 2026

About Shenzhen YHLO Biotech

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China. [Read more]

Sector Healthcare
Founded 2008
Employees 1,678
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688575
Full Company Profile

Financial Performance

In 2024, Shenzhen YHLO Biotech's revenue was 2.01 billion, a decrease of -2.02% compared to the previous year's 2.05 billion. Earnings were 301.53 million, a decrease of -15.06%.

Financial Statements